9.43
price down icon7.64%   -0.78
after-market 시간 외 거래: 9.19 -0.24 -2.55%
loading
전일 마감가:
$10.21
열려 있는:
$10.27
하루 거래량:
114.23K
Relative Volume:
1.60
시가총액:
$50.46M
수익:
$7.97M
순이익/손실:
$-75.74M
주가수익비율:
-0.3883
EPS:
-24.2853
순현금흐름:
$-85.33M
1주 성능:
-6.36%
1개월 성능:
-11.95%
6개월 성능:
+136.34%
1년 성능:
+36.87%
1일 변동 폭
Value
$9.28
$10.31
1주일 범위
Value
$9.28
$10.65
52주 변동 폭
Value
$3.76
$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name
명칭
Aligos Therapeutics Inc
Name
전화
(800) 466-6059
Name
주소
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Name
직원
70
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
ALGS's Discussions on Twitter

ALGS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ALGS
Aligos Therapeutics Inc
9.43 70.97M 7.97M -75.74M -85.33M -24.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-18 재개 H.C. Wainwright Buy
2024-08-19 개시 H.C. Wainwright Buy
2023-01-06 업그레이드 Jefferies Hold → Buy
2023-01-06 업그레이드 Piper Sandler Neutral → Overweight
2022-03-23 다운그레이드 Piper Sandler Overweight → Neutral
2022-01-07 다운그레이드 JP Morgan Overweight → Neutral
2022-01-06 다운그레이드 Jefferies Buy → Hold
2021-09-09 개시 SVB Leerink Outperform
2021-05-17 재개 Piper Sandler Overweight
2020-11-10 개시 Cantor Fitzgerald Overweight
2020-11-10 개시 JP Morgan Overweight
2020-11-10 개시 Jefferies Buy
2020-11-10 개시 Piper Sandler Overweight
모두보기

Aligos Therapeutics Inc 주식(ALGS)의 최신 뉴스

pulisher
Oct 12, 2025

Why Aligos Therapeutics Inc. stock appeals to dividend seekersWeekly Profit Report & Weekly Breakout Opportunity Watchlist - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Will Aligos Therapeutics Inc. (5WK0) stock gain from green policiesEarnings Performance Report & Weekly Momentum Stock Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using data tools to time your Aligos Therapeutics Inc. exit2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why Aligos Therapeutics Inc. is moving todayWeekly Trade Review & AI Enhanced Market Trend Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How Aligos Therapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Aligos Therapeutics Inc. stock bottoming outMarket Sentiment Review & Verified Momentum Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What momentum shifts mean for Aligos Therapeutics Inc.Gold Moves & Real-Time Chart Breakout Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Does Aligos Therapeutics Inc. qualify in momentum factor screeningTrade Analysis Report & Community Consensus Trade Signals - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Aligos Therapeutics (NASDAQ:ALGS) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Published on: 2025-10-08 08:18:12 - earlytimes.in

Oct 07, 2025
pulisher
Oct 07, 2025

Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025 - Investing News Network

Oct 07, 2025
pulisher
Oct 07, 2025

Aligos Therapeutics, Inc. Announces Eight Presentations at The Liver Meeting® 2025, Including Oral Presentation on Novel HBV Therapy - Quiver Quantitative

Oct 07, 2025
pulisher
Oct 07, 2025

8 Abstracts Accepted — Aligos Presents Oral 96‑Week ALG-000184 HBV Data at The Liver Meeting 2025 - Stock Titan

Oct 07, 2025
pulisher
Oct 06, 2025

Is Aligos Therapeutics Inc 5WK0 a good long term investmentStop Loss Placement Tips & High Profit Stock Alerts - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Aligos Therapeutics reports new PD-1/PD-L1 interaction inhibitors - BioWorld MedTech

Oct 06, 2025
pulisher
Oct 06, 2025

Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosPortfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitorsJuly 2025 Final Week & Real-Time Stock Price Movement Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How strong is Aligos Therapeutics Inc. stock balance sheetWeekly Trend Summary & Smart Money Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How Aligos Therapeutics Inc. (5WK0) stock trades in high volatility2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Aligos Therapeutics Inc. stock daily chart insightsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

What to do if you’re stuck in Aligos Therapeutics Inc.July 2025 Sector Moves & Fast Gain Stock Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

D pipeline2025 Big Picture & Real-Time Price Movement Reports - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Aligos Therapeutics (NASDAQ:ALGS) Shares Up 5% – Should You Buy? - Defense World

Oct 02, 2025
pulisher
Sep 30, 2025

What drives First Tellurium Corp G1J stock priceTake Profit Strategies & Minimal Capital Trading Tips - earlytimes.in

Sep 30, 2025

Aligos Therapeutics Inc (ALGS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
자본화:     |  볼륨(24시간):